Ranbaxy gets FDA nod for Ganciclovir
Ranbaxy Laboratories has received approval from the US Food and Drug Administration (FDA) to manufacture and commercialise Ganciclovir Capsules in 250 mg and 500 mg strengths. The Division of
Ranbaxy Laboratories has received approval from the US Food and Drug Administration (FDA) to manufacture and commercialise Ganciclovir Capsules in 250 mg and 500 mg strengths. The Division of